title: [Evidence exists for prophylactic magnesium sulphate as a neuroprotector in premature births].
abstract: Preterm birth increases the child's risk of cerebral palsy. Observational studies as well as randomized studies find that magnesium sulphate given to women in preterm birth decreases such risk. A Cochrane meta-analysis of the randomized studies shows no change in mortality, whereas some observational studies find a mortality decrease. It is important to identify the neuroprotective mechanism and to decide whether these results are relevant in the current Danish obstetrical practice. Should we use magnesium sulphate now or should questions about doses, time of administration and maternal side effects be answered first?
authors: Medicinsk Afdeling, Nykøbing Falster Sygehus, 4800 Nykøbing Falster, Denmark. trapwolf@hotmail.com
authors: Hanne Trap
authors: HT
authors: Wolf
authors: Hanne Kristine
authors: HK
authors: Hegaard
authors: Lene
authors: L
authors: Huusom
authors: Gorm
authors: G
authors: Greisen
authors: Morten
authors: M
authors: Hedegaard
mesh_terms: D002547:Cerebral Palsy / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008278:Magnesium Sulfate / Q000008:administration & dosage* / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D018696:Neuroprotective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D011247:Pregnancy; D012307:Risk Factors; D015149:Tocolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D018696:Neuroprotective Agents; D015149:Tocolytic Agents; D008278:Magnesium Sulfate